Abstract
The decision to implement a new medical technology requires that if not only increases survival or quality of life, but that it is also economically sound. The unique feature in the assessment of diagnostic tests is that the results of such tests are intermediate outcomes. Both randomized controlled clinical trials and decision analysis have an important role to play in the assessment of diagnostic tests. Important points to consider when performing a cost-effectiveness study are what perspective to take; comparing the technology with the next best strategy; including both effectiveness and costs; the distinction between describing and valuing the quality of life; intangibles such as the value of information; and the incremental cost-effectiveness ratio.
Similar content being viewed by others
References
Weinstein MC, Fineberg HV (1980) Clinical decision analysis. WB Saunders, Philadelphia
Pauker SG, Kassirer JP (1987) Medical progress: decision analysis. N Engl J Med 316: 250–258
Drummond MF, Stoddart GL, Torrance GW (1987) Methods for the economic evaluation of health care programmes. Oxford Medical Publications, Oxford, pp 1–182
Weinstein MC, Stason WB (1977) Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 296: 716–721
Detsky AS, Naglie IG (1990) A clinician's guide to cost-effectiveness analysis. Ann Intern Med 113: 147–154
Powe NR (1994) Economic and cost-effectiveness investigations of radiologic practices. Radiology 192: 11–18
Doubilet PM, Weinstein MC, McNeil BJ (1986) Use and misuse of the term “cost effective” in medicine. N Engl J Med 314: 253–256
Caro JJ, Trindade E, McGregor M (1992) The cost-effectiveness of replacing high-osmolality with low-osmolality contrast media. AJR 159: 869–874
Steinberg EP, Moore RD, Powe NR, Gopalan R, Davidoff AJ, Litt M, Graziano S, Brinker JA (1992) Safety and cost-effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. N Engl J Med 326: 425–430
Goel V, Deber RB, Detsky AS (1989) Nonionic contrast media: economic analysis and health policy development. Can Med Assoc J 140: 389–395
Jacobson PD, Rosenquist CJ (1988) The introduction of low-osmolar contrast agents in radiology: medical, economic, legal, and public policy issues. JAMA 260: 1586–1592
Sutherland JB, Huda W (1989) Costs and benefits of low-osmolality contrast agents in radiology. Can Assoc Radiol J 40: 18–21
Powe NR, Steinberg EP, Erickson JE, Moore RD, Smith CR, White RI Jr, Brinker JA, Fishman EK, Zinreich SJ, Kinnison ML (1988) Contrast medium-induced adverse reactions: economic outcome. Radiology 169: 163–168
Sonnenberg FA, Beck JR (1993) Markov models in medical decision making: a practical guide. Med Decis Making 13: 322–338
Metz CE (1986) ROC methodology in radiological imaging. Invest Radiol 21: 720–733
Hanley JA (1989) Receiver operating characteristic (ROC) methodology: the state of the art. Crit Rev Diagn Imaging 29: 307–335
Begg CB, McNeil BJ (1988) Assessment of radiologic tests: control of bias and other design considerations. Radiology 167: 565–569
Begg CB, Greenes A (1983) Assessment of diagnostic tests when disease verifications is subject to selection bias. Biometrics 39: 207–215
Hunink MGM, Richardson D, Doubilet PM, Begg CB (1990) Testing for fetal pulmonary maturity: an ROC analysis involving covariates, verification bias and combination testing. Med Decis Making 10: 201–211
Hunink MGM, Polak JF, Barlan MM, O'Leary DH (1993) Detection and quantification of carotid artery stenosis: efficacy of various Doppler velocity parameters. AJR 160: 619–625
Phelps CE, Mushlin AI (1988) Focusing technology assessment using medical decision therapy. Med Decis Making 8: 279–289
Mushlin AI, Mooney C, Grow V, Phelps CE (1994) The value of diagnostic information to patients with suspected multiple sclerosis. Rochester-Toronto MRI Study Group. Arch Neurol 51: 67–72
Appel LJ, Steinberg EP, Powe NR, Anderson GF, Dwyer SA, Faden RR (1990) Risk reduction from low osmolality contrast media. Med Care 28: 324–337
Der Simonian R, Laird N (1986) Meta-analysis in clinical trials. Controlled Clin Trials 7: 177–188
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719–748
Hunink MG, Wong JB (1994) Meta-analysis of failure-time data with adjustment for covariates. Med Decis Making 14: 59–70
Eddy DM, Hasselblad V, Shachter RD (1992) Meta-analysis by the confidence profile method: the statistical synthesis of evidence. Academic Press, Boston
Littenberg B, Moses LE (1993) Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making 13: 313–321
Caro JJ, Trindade E, McGregor M (1991) The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis. AJR 156: 825–832
Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, Harrington DP (1994) Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making 14: 71–81
Hinink MG, Wong JB, Donaldson MC, Meyerovitz MF, Vries JA de, Harrington DP (1995) Revascularization for femoropopliteal disease: a decision and cost-effectiveness analysis. JAMA 274: 165–171
Koopmanschap MA, Ineveld BM van (1992) Towards a new approach for estimating indirect costs of disease. Soc Sci Med 34: 1005–110
Koopmanschap MA, Rutten FFH, Inenveld, BM van, Roijen L van (1995) The friction cost method for measuring indirect costs of disease. J Health Econ 14(2): 171–189
Hillner BE, Philbrick JT, Becker DM (1992) Optimal management of suspected lower-extremity deep vein thrombosis: an evaluation with cost assessment of 24 management strategies. Arch Intern Med 152: 165–175
Hunink MG, Bos JJ (1995) Triage of patients to angiography for detection of aortic rupture after blunt chest trauma: cost-effectiveness analysis of using CT. AJR 165: 27–36
Yin D, Baum RA, Carpenter JP, Langlotz CP, Pentecost MJ (1995) Cost-effectiveness of MR angiography in cases of limb-threatening peripheral vascular disease. Radiology 194: 757–764
Eddy DM, Hasselblad V, McGivney W, Hendee W (1988) The value of mammography screening in women under age 50 years. JAMA 259: 1512–1519
Author information
Authors and Affiliations
Additional information
Adjunct appointments: University Hospital Groningen, The Netherlands and Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, USA
Correspondence to: M. G. M. Hunink
Rights and permissions
About this article
Cite this article
Hunink, M.G.M. Outcomes research and cost-effectiveness analysis in radiology. Eur. Radiol. 6, 615–620 (1996). https://doi.org/10.1007/BF00187659
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00187659